Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$111.0M
total disclosed, rounds participated
Stages
—
Portfolio · 1
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Surveyor Capital's most recent exit?
- Surveyor Capital's most recent exit was ImmPACT Bio, which was acquired by Lyell Immunopharma in October 2024.
- Which sector does Surveyor Capital primarily focus on for its investments?
- Surveyor Capital shows a concentration in the Health Tech & Life Sciences sector, with all its portfolio companies and exits falling within this area.
- Can you name a notable company in Surveyor Capital's portfolio?
- A notable company in Surveyor Capital's portfolio is ImmPACT Bio, which develops CAR-T Cell Therapies for treating cancer.
- What is the most common funding stage for Surveyor Capital's investments?
- Surveyor Capital has participated in B Round funding stages, which represents its sole recorded investment round.
- When did Surveyor Capital make its most recent investment?
- Surveyor Capital made its most recent investment in January 2022.
- What is the total amount raised by ImmPACT Bio, a company in Surveyor Capital's portfolio?
- ImmPACT Bio, a company in Surveyor Capital's portfolio, raised $137M.